Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gliosarcoma × trebananib × 1 year × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasms 1 Melanoma 1 Kidney Neoplasms 1 Hemangiosarcoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Temozolomide 15 Radiotherapy 10 Radiation 9 Magnetic Resonance Spectroscopy 7 Specimen Handling 5 pembrolizumab 4 Ipilimumab 3 atezolizumab 2 Photons 2 Nivolumab 2 Biopsy 2 veliparib 1 tinostamustine 1 selinexor 1 sargramostim 1 plerixafor 1 peposertib 1 pazopanib 1 navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid 1 montanide ISA 51 1 gosha-jinki-gan 1 fluorodopa F 18 1 ferric pyrophosphate 1 efineptakin alfa 1 cemiplimab 1 cabozantinib 1 abexinostat 1 X-Rays 1 Vorinostat 1 Utrogestan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡